Edition:
United Kingdom

Vivus Inc (VVUS.OQ)

VVUS.OQ on NASDAQ Stock Exchange Global Select Market

0.80USD
18 May 2018
Change (% chg)

$0.18 (+28.14%)
Prev Close
$0.62
Open
$0.65
Day's High
$0.84
Day's Low
$0.65
Volume
1,205,630
Avg. Vol
161,628
52-wk High
$1.38
52-wk Low
$0.33

Chart for

About

VIVUS, Inc. is a biopharmaceutical company. The Company operates in the development and commercialization of therapeutic products segment. It provides over two therapies approved by the Food and Drug Association (FDA), which include Qsymia (phentermine and topiramate extended-release) for chronic weight management and STENDRA... (more)

Overall

Beta: 0.90
Market Cap(Mil.): $66.20
Shares Outstanding(Mil.): 106.04
Dividend: --
Yield (%): --

Financials

  VVUS.OQ Industry Sector
P/E (TTM): -- 28.57 32.53
EPS (TTM): -0.38 -- --
ROI: -16.57 13.08 12.63
ROE: -- 14.80 14.50

BRIEF-Vivus Announces Change In Leadership

* VIVUS INC - BOARD MEMBER THOMAS B. KING APPOINTED INTERIM CEO

26 Dec 2017

Competitors

Earnings vs. Estimates